Back to today’s briefing

Story perspectives

Liquid Biopsies Transform Metastatic Breast Cancer Treatment

6/2/2025

43 3

Summary

Story summary

A groundbreaking study at the American Society of Clinical Oncology reveals that liquid biopsies can identify early drug resistance in metastatic breast cancer. By transitioning to the experimental drug camizestrant, patients experienced extended tumor control and enhanced quality of life. This innovative strategy could revolutionize treatment for hormone receptor-positive, HER2-negative breast cancer.

1 of 1

Story summary

A groundbreaking study at the American Society of Clinical Oncology reveals that liquid biopsies can identify early drug resistance in metastatic breast cancer. By transitioning to the experimental drug camizestrant, patients experienced extended tumor control and enhanced quality of life. This innovative strategy could revolutionize treatment for hormone receptor-positive, HER2-negative breast cancer.